Skip to main content
SpringerLink
Log in

Evolving symbiosis—venture capital and biotechnology

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A Corrigendum to this article was published on 01 April 2007

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Private funding of biotechnology ventures over the past 8 years.

Author information

Authors and Affiliations

  1. Ernst & Young, 1111 Summer Street, Stamford, 06905, Connecticut, USA

    Terry C Bradford

Authors
  1. Terry C Bradford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bradford, T. Evolving symbiosis—venture capital and biotechnology. Nat Biotechnol 21, 983–984 (2003). https://doi.org/10.1038/nbt0903-983

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0903-983

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation